Chronic HCV Infection: Clinical Advances and Eradication Perspectives

Hepatitis C virus (HCV) chronic infection can determine liver fibrosis, cirrhosis and hepatocellular carcinoma, as well as several extra-hepatic manifestations (i.e., mixed cryoglobulinemia, metabolic syndrome, kidney disease, etc.). HCV infection is asymptomatic until severe stages of disease, thus...

Full description

Saved in:
Bibliographic Details
Other Authors: Liberto, Maria Carla (Editor), Marascio, Nadia (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_79675
005 20220321
003 oapen
006 m o d
007 cr|mn|---annan
008 20220321s2022 xx |||||o ||| 0|eng d
020 |a books978-3-0365-3362-9 
020 |a 9783036533612 
020 |a 9783036533629 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-3362-9  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a MBNS  |2 bicssc 
100 1 |a Liberto, Maria Carla  |4 edt 
700 1 |a Marascio, Nadia  |4 edt 
700 1 |a Liberto, Maria Carla  |4 oth 
700 1 |a Marascio, Nadia  |4 oth 
245 1 0 |a Chronic HCV Infection: Clinical Advances and Eradication Perspectives 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (104 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Hepatitis C virus (HCV) chronic infection can determine liver fibrosis, cirrhosis and hepatocellular carcinoma, as well as several extra-hepatic manifestations (i.e., mixed cryoglobulinemia, metabolic syndrome, kidney disease, etc.). HCV infection is asymptomatic until severe stages of disease, thus screening policy in the general population and in specific risk categories is necessary to allow for timely intervention. Despite a high sustained virological response by direct-acting antiviral drugs, a limited percentage of treated subject failed therapy according to resistance associated substitution carried on viral isolates and comorbidities in infected patients. Therefore, tailored therapy is required to cure HCV infection. Failure to comply with these conditions may impair success of HCV eradication expected by 2030. This Special Issue aims to discuss eradication perspectives related to therapy efficacy in patients with chronic diseases, developments in diagnostic procedures and improvements in screening policy. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Epidemiology & medical statistics  |2 bicssc 
653 |a HCV 
653 |a rheumatic 
653 |a interferon 
653 |a mortality 
653 |a hepatitis C virus (HCV) 
653 |a phylogeny 
653 |a resistance-associated substitution (RAS) 
653 |a chronic hepatitis C 
653 |a vibration controlled transient elastography 
653 |a fibrosis 
653 |a steatosis 
653 |a hepatocellular carcinoma 
653 |a hepatitis C 
653 |a genotype 3 
653 |a liver cirrhosis 
653 |a pangenotypic 
653 |a children 
653 |a ledipasvir/sofosbuvir 
653 |a real-life 
653 |a sustained virological response 
653 |a elimination 
653 |a model 
653 |a COVID-19 
653 |a PWID 
653 |a homeless persons 
653 |a HCV eradication 
653 |a direct-acting antivirals 
653 |a out-of-hospital 
653 |a retention in care 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/5060  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/79675  |7 0  |z DOAB: description of the publication